A model for retention and continuity of care and treatment for opioid dependent injection drug users in the Russian Federation

Elena Dmitrieva, Sergei A. Frolov, Thomas F. Kresina, William Slater

Division of Pharmacologic Therapies, Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration, Rockville, USA.
Health and Development Foundation, Moscow, Russia.
Health Team, United States Agency for International Development, Moscow, Russia.

DOI: 10.4236/health.2012.48073                

Abstract

Health and Development Foundation has worked collaboratively with the Government of the Russian Federation to develop and implement a model program of retention and continuity of care for opioid dependence and HIV infection. The model utilizes the Narcology Detoxification Service, State AIDS Centers, Non Government Organization (NGO) managed narcology treatment and rehabilitation centers, NGO outreach programs and the community. The model program was developed and implemented as a pilot demonstration project to provide essential health services to injection drug users and retain them in care. The interventions developed and implemented comprised HIV Testing and Counseling, HIV/AIDS Narcology Post-Graduate Curriculum, Peer Support Groups (Buffer groups), Narcological Follow-up Phone Monitoring, Women’s Narcological Services and Short Messaging Services for Injection Drug Users. These services and interventions promoted the integration and utilization of HIV/AIDS health services and narcological services to form an evidence-based health service delivery model providing essential services to people who inject drugs and people living with HIV/AIDS in the Russian Federation.

Keywords

Opioid Dependence; Health Services; Retention in Care; Drug Treatment

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Kresina, T.F., Bruce, R.D., Pirard, S., Mulvey, K., Huesca, R.S. and Lubran, R. (2012) International expansion of the use of pharmacotherapies for the treatment of opioid dependence. Clinical and Experimental Pharmacology, in press.
[2]	United Nations Office of Drugs Control (UNODC) (2010) World Drug Report 2010. United Nations Publications, New York, 42-51. http://www.unodc.org/unodc/en/data-and-analysis/WDR-2010.html
[3]	World Health Organization (2010) The international statistical classification of diseases and related health problems. 10th Edition, WHO Press. http://apps.who.int/classifications/icd10/browse/2010/en
[4]	World Health Organization (2009) Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. WHO Press. http://www.who.int/substance_abuse/publications/opioid_dependence_guidelines.pdf
[5]	World Health Organization (2010) Priority interventions. HIV/AIDS prevention, treatment and care in the health sector. World Health Organization HIV/AIDS Department. http://www.who.int/hiv/pub/guidelines/9789241500234/en/index.html
[6]	Kirzhanova, V.V. and Sidoryuk, O.V. (2010) Indicators of general and primary morbidity-related drug disorders in the Russian Federation during 199-2009. http://www.nrca-rf.ru/2_195.html
[7]	Information bulletin No. 34 of the federal scientific-methodological center for the prevention and control of AIDS in the Russian Federation (2010). http://hivrussia.org/files/bul?34.pdf
[8]	Information bulletin No. 33 of the federal scientific-methodological center for the prevention and control of AIDS in the Russian Federation (2009). http://hivrussia.org/files/bul?_33.pdf
[9]	Antoun, J., Phillips, F. and Johnson, T. (2011) Post-soviet transition: Improving health services delivery and management. Mount Sinai Journal of Medicine, 78, 436-448. doi:10.1002/msj.20261
[10]	Kresina, T.F., Lubran, R. and Cheever, L.W. (2011) Substance abuse treatment utilizing medication assisted treatment as HIV prevention. In: HIV Prevention, Intech Publishers, Rijeka, 527-548.
[11]	Lawn, S.D., Fraenzel, A., Kranzer, K., Caldwell, J., Bekker, L.G. and Wood, R. (2011) Provider-initiated HIV testing increases access of patients with HIV-associated tuberculosis to antiretroviral treatment. South African Medical Journal, 101, 258-262.
[12]	Volkow, N.D. and Montaner, J. (2011) The urgency of providing comprehensive and integrated treatment for substance abusers with HIV. Health Affairs (Millwood), 30, 1411-1419. doi:10.1377/hlthaff.2011.0663
[13]	Tracy, K., Burton, M., Nich, C. and Rounsaville, B. (2011) Utilizing peer mentorship to engage high recidivism substance-abusing patients in treatment. American Journal of Drug and Alcohol Abuse, 37, 525-531. doi:10.3109/00952990.2011.600385
[14]	Mukund Bahadur, K.-C. and Murray, P.J. (2010) Cell phone short messaging service (SMS) for HIV/AIDS in South Africa: A literature review. Studies in Health Technology and Informatics, 160, 530-534.
[15]	Wright, E., Fortune, T., Juzang, I. and Bull, S. (2011) Text messaging for HIV prevention with young black men: Formative research and campaign development. AIDS Care, 23, 534-541. doi:10.1080/09540121.2010.524190
[16]	Conviser, R. and Pounds, M.B. (2002) Background for the studies on ancillary services and primary care use. AIDS Care, 14, S7-S14. doi:10.1080/09540120220149993
[17]	Purcell, D.W., Latka, M.H., Metsch, L.R. and INSPIRE Study Team (2007) Results from a randomized controlled trial of a peer-mentoring intervention to reduce HIV transmission and increase access to care and adherence to HIV medications among HIV-seropositive injection drug users. Journal of the Acquired Immune Deficiency Syndrome, 46, S35-S47.
[18]	Roux, P., Carrieri, M.P., Cohen, J., Ravaux, I., PoizotMartin, I., Dellamonica, P. and Spire, B. (2009) Retention in opioid substitution treatment: A major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment. Clinical Infectious Diseases, 49, 1433-1440. doi:10.1086/630209